Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease

BACKGROUND: A recent trial involving predominantly Caucasian subjects with Parkinson Disease (PD) showed switching overnight from an oral dopaminergic agonist to the rotigotine patch was well tolerated without loss of efficacy. However, no such data have been generated for Korean patients. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Han-Joon, Jeon, Beom S, Lee, Won Yong, Lee, Myoung Chong, Kim, Jae Woo, Kim, Jong-Min, Ahn, Tae-Beom, Cho, Jinwhan, Chung, Sun Ju, Grieger, Frank, Whitesides, John, Boroojerdi, Babak
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166898/
https://ncbi.nlm.nih.gov/pubmed/21831297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-11-100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados